- Home
- CDRE vs PRME Comparison
CDRE vs PRME Comparison
Compare CDRE & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDRE | PRME |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 601.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CDRE | PRME |
|---|---|---|
| Price | $40.60 | $3.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $34.50 | $6.42 |
| AVG Volume (30 Days) | 268.7K | ★ 3.3M |
| Earning Date | 11-04-2025 | 11-07-2025 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | ★ 33.82 | N/A |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $619,068,000.00 | $5,977,000.00 |
| Revenue This Year | $12.51 | $111.80 |
| Revenue Next Year | $8.21 | N/A |
| P/E Ratio | $36.54 | ★ N/A |
| Revenue Growth | 19.94 | ★ 647.13 |
| 52 Week Low | $27.07 | $1.11 |
| 52 Week High | $46.64 | $6.94 |
Technical Indicators
Market Signals| Indicator | CDRE | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 43.14 |
| Support Level | $40.22 | $3.95 |
| Resistance Level | $42.47 | $4.12 |
| Average True Range (ATR) | 1.44 | 0.34 |
| MACD | -0.32 | 0.02 |
| Stochastic Oscillator | 8.76 | 34.91 |
Price Performance
Historical ComparisonAbout CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.